Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Peptide free, MALS verified)

ユーザーレビュー
製品番号/仕様
価格
数量
HL1-H82W6-25ug
$125.00
HL1-H82W6-200ug
$700.00
ETA of in-stock products:2 business days
総アイテム数 製品金額$ 0

製品詳細

  • Synonyms

    HLA-DRA1*0101 & HLA-DRB1*1101

  • Source

    Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (HL1-H82W6) is expressed from human 293 cells (HEK293). It contains AA Ile 26 - Glu 216 (HLA-DRA1*01:01) & Gly 30 - Lys 227 (HLA-DRB1*11:01) (Accession # CAI2388006.1 (HLA-DRA1*01:01) & CAI2388099.1 (HLA-DRB1*11:01)).

    Predicted N-terminus: Ile 26 & Gly 30

    Request for sequence
  • Molecular Characterization

    Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein, produced by co-expression of HLA-DRA1*01:01 and HLA-DRB1*11:01, has a calculated MW of 29.2 kDa (HLA-DRA1*01:01) and 29.2 kDa (HLA-DRB1*11:01). Subunit HLA-DRA1*01:01 is fused with a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag™) and subunit HLA-DRB1*11:01 contains no tag. The protein migrates as 40-43 kDa and 35-38 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Purity

    >90% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

お客様はこちらも閲覧

データ表示

  • SDS-PAGE

    HLA-DRA1*0101 & HLA-DRB1*1101 SDS-PAGE

    Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    HLA-DRA1*0101 & HLA-DRB1*1101 SEC-MALS

    The purity of Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Cat. No. HL1-H82W6) is more than 90% and the molecular weight of this protein is around 55-75 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     HLA-DRA1*0101 & HLA-DRB1*1101 ELISA

    Immobilized Biotinylated Human HLA-DRA1*01:01&HLA-DRB1*11:01 Monomer Protein (Cat. No. HL1-H82W6) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Anti-HLA-DR Antibody, Human IgG1 with a linear range of 0.06-2 ng/mL (QC tested).

    Protocol

ユーザーレビュー
コメントを投稿

最新の進展

 
お問い合わせ
医薬品候補ライセンス
他の関連情報
  • 製品情報
  • 製品詳細
  • お客様はこちらも閲覧
  • データ表示
  • ユーザーレビュー
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8